bioAffinity Technologies News Update

3d ago, source:

SAN ANTONIO, May 02, 2024--bioAffinity reports ramp in sales of CyPath® Lung, expanded sales team, new Patient Coach and ...

BioAffinity Technologies Inc (BIAF) Stock: Evaluating the Annual Growth

11d ago, source: newsheater

In a nutshell, BioAffinity Technologies Inc (BIAF) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note ...

BIAFW bioAffinity Technologies, Inc. C/WTS 12/08/27 (TO PUR COM)

10d ago, source: Seeking Alpha

**NM signifies a non meaningful value. A dash signifies the data is not available.

bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth

11d ago, source: The Bakersfield Californian

Affinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung cancer and other lung diseases, ...

bioAffinity Technologies, Inc. Warrant (BIAFW)

13d ago, source: Nasdaq

*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green highlights the top performing ETF by % change in the past ...

bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening

26d ago, source: The Bakersfield Californian

bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage cancer and lung disease ...

bioAffinity Technologies, Inc. (BIAF)

2mon ago, source: Yahoo Finance

WallachBeth Capital LLC, a leading provider of capital markets and institutional execution services, announced today that bioAffinity Technologies, Inc. (Nasdaq: BIAF and BIAFW) has closed a ...

bioAffinity Technologies Inc BIAF

4d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

bioAffinity Technologies Inc.

20d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...